Provider: Nature Publishing Group
Content: application/x-research-info-systems
TY  - JOUR

AU  - Levy, D.

AU  - Garrison, R.J.

AU  - Savage, D.D.

AU  - Kannel, W.B.

AU  - Castelli, W.P.

TI  - Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

JO  - N. Engl. J. Med.

PY  - 1990///

VL  - 322

SP  - 1561

EP  - 6

ER  - 



TY  - JOUR

AU  - Hunter, J.J.

AU  - Chien, K.R.

TI  - Signaling pathways for cardiac hypertrophy and failure

JO  - N. Engl. J. Med.

PY  - 1999///

VL  - 341

SP  - 1276

EP  - 83

M3  - 10.1056/NEJM199910213411706

N1  - 10.1056/NEJM199910213411706

UR  - http://dx.doi.org/10.1056/NEJM199910213411706

ER  - 



TY  - JOUR

AU  - Asakura, M.

TI  - Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloprotease inhibitors as a potential new therapy for cardiac hypertrophy

JO  - Nature Med.

PY  - 2001///

VL  - 8

SP  - 35

EP  - 40

M3  - 10.1038/nm0102-35

N1  - 10.1038/nm0102-35

UR  - http://dx.doi.org/10.1038/nm0102-35

ER  - 



TY  - JOUR

AU  - Black, R.A.

AU  - White, J.M.

TI  - ADAMs: focus on the protease domain

JO  - Curr. Opin. Cell. Biol.

PY  - 1998///

VL  - 10

SP  - 654

EP  - 659

M3  - 10.1016/S0955-0674(98)80042-2

N1  - 10.1016/S0955-0674(98)80042-2

UR  - http://dx.doi.org/10.1016/S0955-0674(98)80042-2

ER  - 



TY  - JOUR

AU  - Prenzel, N.

TI  - EGF receptor transactivation by G-protein-coupled receptors requires metalloprotease cleavage of proHB-EGF

JO  - Nature

PY  - 1999///

VL  - 402

SP  - 884

EP  - 888

M3  - 10.1038/47260

N1  - 10.1038/47260

UR  - http://dx.doi.org/10.1038/47260

ER  - 



TY  - JOUR

AU  - Moss, M.L.

TI  - Cloning of a disintegrin metalloprotease that processes precursor tumour-necrosis factor-[alpha]

JO  - Nature

PY  - 1997///

VL  - 385

SP  - 733

EP  - 736

M3  - 10.1038/385733a0

N1  - 10.1038/385733a0

UR  - http://dx.doi.org/10.1038/385733a0

ER  - 



TY  - JOUR

AU  - Li, Y.Y.

TI  - Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor[alpha] therapy

JO  - Proc. Natl. Acad. Sci. USA

PY  - 2000///

VL  - 97

SP  - 12746

EP  - 12751

M3  - 10.1073/pnas.97.23.12746

N1  - 10.1073/pnas.97.23.12746

UR  - http://dx.doi.org/10.1073/pnas.97.23.12746

ER  - 



TY  - JOUR

AU  - Rogers, J.H.

TI  - RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload

JO  - J. Clin. Invest.

PY  - 1999///

VL  - 104

SP  - 567

EP  - 576

ER  - 



TY  - JOUR

AU  - Wettschureck, N.

TI  - Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G[alpha]q/G[alpha]11 in cardiomyocytes

JO  - Nature Med.

PY  - 2001///

VL  - 7

SP  - 1236

EP  - 12340

M3  - 10.1038/nm1101-1236

N1  - 10.1038/nm1101-1236

UR  - http://dx.doi.org/10.1038/nm1101-1236

ER  - 



TY  - JOUR

AU  - Slamon, D.J.

TI  - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2

JO  - N. Engl. J. Med.

PY  - ///

VL  - 344

SP  - 783

EP  - 792

M3  - 10.1056/NEJM200103153441101

N1  - 10.1056/NEJM200103153441101

UR  - http://dx.doi.org/10.1056/NEJM200103153441101

ER  - 



TY  - JOUR

AU  - Takemoto, M.

TI  - Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

JO  - J. Clin. Invest.

PY  - 2001///

VL  - 108

SP  - 1429

EP  - 1437

M3  - 10.1172/JCI200113350

N1  - 10.1172/JCI200113350

UR  - http://dx.doi.org/10.1172/JCI200113350

ER  - 



TY  - JOUR

AU  - Daub, H.

AU  - Weiss, F.U.

AU  - Wallasch, C.

AU  - Ullrich, A.

TI  - Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

JO  - Nature

PY  - 1996///

VL  - 379

SP  - 557

EP  - 560

M3  - 10.1038/379557a0

N1  - 10.1038/379557a0

UR  - http://dx.doi.org/10.1038/379557a0

ER  -